FDA approves virtual reality rehab device for stroke, brain injury patients

The Food and Drug Administration on Wednesday approved MindMaze's upper-limb rehabilitation platform, MindMotion Pro.

The neuro-technology platform uses 3-D motion tracking cameras, creating a virtual reality environment to aid stroke patients and individuals with other traumatic injuries.

The platform maps patients' movements onto 3-D avatars and leads them through various rehabilitation exercises based on "standardized neurorehabilitation principles," according to a news release.

Patients can use the platform as soon as four days post-stroke.

More articles on supply chain:

Viewpoint: Why healthcare needs more 'me too' drugs
Viewpoint: Pharma should give trial participants a say in pricing new drugs
Magellan vein-based blood tests underreported lead levels, says health officials

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months